Metabolomic signatures reflective of a healthy diet were linked to a reduced risk of developing radiographic knee OA, with BMI serving as a key mediator.

The prevalence of obesity in the United States increased from 1990 to 2022 and has been predicted to continue through 2035.

Individuals with gout showed distinct inflammatory biomarker patterns, with profiles moving closer to those of nongout control individuals with use of treat-to-target ULT.

Most US adults did not know about nonstatin medications and were not aware of lipoprotein(a) or coronary artery calcium scores.

Ongoing cuts in global aid from the US and other donors were estimated to lead to 9.4 million additional deaths by 2030.

In fibrotic ILD, desaturation recovery post 6MWT is linked to disease progression, baseline disease severity, and transplant-free survival.

The number of live births in the US decreased while the racial and ethnic makeup of births changed from 2016 to 2024.

Anifrolumab, a type I interferon receptor antagonist, is currently approved under the brand name Saphnelo ® for intravenous administration in the treatment of moderate to severe SLE. If approved, a ...

The Centers for Medicare and Medicaid Services said they would increase oversight of organ procurement and use more medically complex organs.

The Opioid Risk Tool for Opioid Use Disorder may help identify patients with chronic noncancer pain at increased risk for OUD ...

Patients with gout who were newly prescribed urate-lowering treatment and achieved a serum urate level lower than 6 mg/dL had ...

Close to half of the CDC surveillance databases which were previously updated monthly had been paused in 2025.